MoneyWorks4Me

Supriya Lifescience informs about analyst meet intimation

03 Dec 2022 Evaluate
Pursuant to the relevant provisions of the SEBI Listing Regulations, Supriya Lifescience has informed that the officials of the Company, Supriya Lifescience ('Company') will participate in conference and interact with Investors /Analysts in person on December 7, 2022.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1760.60
Dr. Reddys Labs. 1220.75
Cipla 1333.70
Lupin 1959.20
Zydus Lifesciences 1140.75
View more..